Intra-prefrontal cortex injections of SCH 23390 influence nucleus accumbens dopamine levels 24 h post-infusion

Brain Research

Volumn 922, Issue 1, 2001, Pages 80-86

  Olsen, Christopher M ^a   Duvauchelle, Christine L ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

In vivo microdialysis; Mesoaccumbens; Prelimbic cortex; Rat

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; NEUROTRANSMITTER;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ABUSE; MALE; NEUROPHARMACOLOGY; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VENTRAL TEGMENTUM;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; BEHAVIOR, ANIMAL; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; INJECTIONS; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1;

EID: 0035856877     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)03152-3     Document Type: Article

References (65)

1. D1 dopamine receptor activation reduces extracellular glutamate and GABA concentrations in the medial prefrontal cortex
2. Partial and full dopamine D1 receptor agonists in mice and rats: Relation between behavioural effects and stimulation of adenylate cyclase activity in vitro
3. Possible involvement of medial prefrontal cortex in amphetamine-induced sensitization of mesolimbic dopamine function
4. Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions
5. Dopamine depletion in the medial prefrontal cortex induces sensitized-like behavioral and neurochemical responses to cocaine
6. Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: Radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome
7. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors
8. 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze
9. Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens
10. Projections from the rat prefrontal cortex to the ventral tegmental area: Target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons
11. Behavioral and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat
12. Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area
13. An excitant amino acid projection from the medial prefrontal cortex to the anterior part of the nucleus accumbens in the rat
14. High-resolution scatchard analysis shows D1 receptor binding on pyramidal and nonpyramidal neurons
15. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress
16. Medial prefrontal cortical D1 receptor modulation of the meso-accumbens dopamine response to stress: An electrochemical study in freely-behaving rats
17. Prefrontal cortex infusions of SCH 23390 cause immediate and delayed effects on ventral tegmental area stimulation reward
18. Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward
19. Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices
20. D1 and D2 receptor gene expression in the rat frontal cortex: Cellular localization in different classes of efferent neurons
21. Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex
22. In vivo and in vitro intracellular recordings from rat midbrain dopamine neurons
23. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex
24. The dopamine D(1) receptor agonist SKF-82958 serves as a discriminative stimulus in the rat
25. Effects of cocaine on dopamine in subregions of the rat prefrontal cortex and their efferents to subterritories of the nucleus accumbens
26. 5-HT receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain
27. GABA(A) receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats
28. Characterization of excitatory amino acid modulation of dopamine release in the prefrontal cortex of conscious rats
29. Differential effects of mesocortical, mesolimbic, and mesostriatal dopamine depletion on spontaneous, conditioned, and drug-induced locomotor activity
30. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area
31. Circuits, drugs, and drug addiction
32. Lesions of dopamine neurons in the medial prefrontal cortex: Effects on self-administration of amphetamine and dopamine synthesis in the brain of the rat
33. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations
34. 3H]SCH23390
35. Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo voltammetric study
36. Expression of D1 receptor mRNA in projections from the forebrain to the ventral tegmental area
37. Effect of medial prefrontal cortex injections of SCH 23390 on intravenous cocaine self-administration under both a fixed and progressive ratio schedule of reinforcement
38. D1 receptor in interneurons of macaque prefrontal cortex: Distribution and subcellular localization
39. Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress
40. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
41. Expression of cocaine sensitization: Regulation by the medial prefrontal cortex
42. Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat
43. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats
44. Non-DA prefronto-cortical efferents modulate D1 receptors in the nucleus accumbens
45. Neurobehavioural mechanisms of reward and motivation
46. Supersensitivity to the reinforcing effects of cocaine following 6-hydroxydopamine lesions to the medial prefrontal cortex in rats
47. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area
48. Dopamine transporter mRNA is up-regulated in the substantia nigra and the ventral tegmental area of amphetamine-sensitized rats
49. Heterogeneous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: A laminar analysis using the silver-enhanced diaminobenzadine sulfide (SEDS) immunolabeling technique
50. Effects of dopamine depletions in the medial prefrontal cortex on DRL performance and motor activity in the rat
51. Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine
52. Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization
53. Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area
54. In vivo stimulated dopamine release in the nucleus accumbens: Modulation by the prefrontal cortex
55. Pharmacology and behavioral pharmacology of the mesocortical dopamine system
56. Immunocytochemical localization of dopamine in the prefrontal cortex of the rat at the light and electron microscopic level
57. Opposed behavioural outputs of increased dopamine transmission in prefrontocortical and subcortical areas: A role for the cortical D-1 dopamine receptor
58. Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens
59. Synaptic regulation of mesocorticolimbic dopamine neurons
60. Neuroadaptations involved in amphetamine and cocaine addiction
61. Brain reward circuitry: Four circuit elements 'wired' in apparent series
62. Relative roles of ventral striatal D1 and D2 dopamine receptors in responding with conditioned reinforcement
63. Contrasting effects of repeated treatment vs. withdrawal of methamphetamine on tyrosine hydroxylase messenger RNA levels in the ventral tegmental area and substantia nigra zona compacta of the rat brain
64. Modulation of medial prefrontal cortical D1 receptors on the excitatory firing activity of nucleus accumbens neurons elicited by (-)-Stepholidine